Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ZC3H12B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CCZ1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MLXIP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARID4B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ZNF148 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COL4A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RUFY2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLPTM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EML2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FRZB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SHMT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GYG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CBL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ESR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TM9SF4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MFAP3L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on